Dr. Joe Larsen Joins SMI?s Life Sciences Practice
“Joe is going to bring SMI’s Life Science Practice to the next level,” said SMI’s COO Bill McCann. “He is a globally recognized leader in the area of public health preparedness. Joe’s counsel will be invaluable to companies looking to develop the next generation of CBRN medical countermeasures with the US Government.”
“I am thrilled to be joining SMI’s Life Science Practice. I look forward to the opportunity to advise companies in this space and advance new technologies that have the potential to transform healthcare,” said Dr. Larsen.
In his role at BARDA, Dr. Larsen oversaw BARDA’s annual $535M advanced research and development portfolio as well as the $2.8 billion Project Bioshield program for the development and procurement of medical products for use during public health emergencies. Dr. Larsen also served as the BARDA lead on antimicrobial resistance, having designed and initiated BARDA’s clinical stage antibiotic program which led to the FDA approval of two novel antibiotics. Dr. Larsen also initiated CARB-X, a $500 million non-profit public-private partnership to combat drug resistant bacteria.
Prior BARDA, Dr. Larsen served as the Senor Science and Technology Manager for Biological Therapeutics at the Department of Defense’s Defense Threat Reduction Agency (DTRA), where he managed basic and applied scientific research leading to the development of therapeutic compounds for viral, bacterial and toxin threat agents.
Dr. Larsen is a former Science and Technology Policy Fellow for the American Association for the Advancement of Science (AAAS) during which time he supported the Department of Homeland Security’s Science and Technology Directorate’s University Programs.
Dr. Larsen earned a BA with Honors in Microbiology from the University of Kansas and PhD in Microbiology with an Emphasis in Emerging Infectious Diseases from the Uniformed Services University of the Health Sciences. He was a Postdoctoral Research Associate at the National Academies.
Founded in 1993, Strategic Marketing Innovations (SMI) has been the premier choice in Washington for companies, universities, nonprofits, and industry associations seeking enhanced strategies for technology development and enterprise growth. Representing over seventy clients nationwide, SMI combines both lobbying and government affairs support with technical consulting services.